Alejandra Bernwieser

Alejandra Bernwieser is an experienced finance professional currently serving as a Business Planning Analysis Manager at Denk Pharma GmbH & Co. KG and as an Advisor at EverLeaf, while also being a Founding Partner at BerCas Capital. Previous roles include Financial Controller at Cazoo and Finance Manager at Immunic Therapeutics, where responsibilities encompassed monthly and quarterly closings, digital finance process improvements, and SOX Framework control management. Alejandra has also worked as a Financial Auditor at KPMG France and held positions at Sanofi Pasteur and COMAP, focusing on financial reporting, headcount analysis, and project expense monitoring. Educational qualifications include a Mastère Spécialisé® in accounting and finance from SKEMA Business School, alongside a Diplôme Grande École de Commerce in International finance from MBS School of Business and a Bachelor's degree in Financial Management from Pontificia Universidad Católica Madre y Maestra.